6MM-11171-13129
4 vaccinations
4 coded responses
35 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 56-60
- ZIP prefix
- 600 / IL
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-09
Registered in v-safe
-
2021-04-09
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
-
2021-04-14
Survey response — days 1–6 daily, dose 1MedDRA: Injection site bruising, Injection site haematoma — Feeling: GoodFree text: Of interest: today was the first sign of a quarter-size hematoma at the injection site. No swelling or pain. Just small bruise.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-15
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-05-14
- 2021-05-21
- 2021-07-09
-
2021-10-08
Survey response — 6 months, dose 1MedDRA: Fatigue, Headache, Oropharyngeal pain, SARS-CoV-2 test, SARS-CoV-2 test negative, Sinus congestion — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Have a sore throat, significant sinus congestion, abnormal headache, and fatigue for about 30 hours. Had a negative rapid COVID test yesterday. Waiting for PCR results. Appears to be some other illness.MedDRA releases: 2024-11 · check-in free text available
-
2021-10-28
Dose 2 — Janssen/Johnson & Johnson
-
2021-10-31
Survey response — days 1–6 daily, dose 2MedDRA: Chills, Fatigue, Headache, Injection site pain, Injection site swelling, No reaction on previous exposure to drug, Pyrexia — Feeling: Fair · Site: Pain, Redness, SwellingFree text: Had no symptoms w/1st shot. Had chills, fever, headache and fatigue about 10 hours after second dose. Lasted about 15 hours. Now just injection site soreness & swelling and mild headache has persisted since on set.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-11-02
- 2021-11-03
- 2021-11-04
- 2021-11-11
- 2021-11-18
- 2021-11-25
- 2021-12-02
- 2021-12-09
- 2022-01-29
-
2022-07-15
Dose 3 — Pfizer-BioNTech
-
2022-10-13
Dose 4 — Pfizer-BioNTech
-
2022-10-17
Survey response — days 1–6 daily, dose 4MedDRA: Adverse reaction — Feeling: Good · Site: Pain · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Didn't experience these today, hit had them start about 10 hours after injection and lasted about 10-12 hours. Enough to rest periodically.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-19
- 2022-10-20
- 2022-10-29
- 2022-11-03
- 2022-11-12
- 2022-11-17
- 2022-11-24
- 2023-01-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-09 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-28 | Janssen/Johnson & Johnson | No |
| 3 | 2022-07-15 | Pfizer-BioNTech | No |
| 4 | 2022-10-13 | Pfizer-BioNTech | No |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Of interest: today was the first sign of a quarter-size hematoma at the injection site. No swelling or pain. Just small bruise.
Release 10 — 6 months, dose 1
Symptoms: Have a sore throat, significant sinus congestion, abnormal headache, and fatigue for about 30 hours. Had a negative rapid COVID test yesterday. Waiting for PCR results. Appears to be some other illness.
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Had no symptoms w/1st shot. Had chills, fever, headache and fatigue about 10 hours after second dose. Lasted about 15 hours. Now just injection site soreness & swelling and mild headache has persisted since on set.
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Didn't experience these today, hit had them start about 10 hours after injection and lasted about 10-12 hours. Enough to rest periodically.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | SARS-CoV-2 test | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Sinus congestion | · | · | ✓ |
| SRO | Adverse reaction | · | · | ✓ |
| SRO | Chills | · | · | ✓ |
| SRO | Fatigue | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
| SRO | Injection site bruising | ✓ | ✓ | ✓ |
| SRO | Injection site haematoma | ✓ | ✓ | ✓ |
| SRO | Injection site pain | · | · | ✓ |
| SRO | Injection site swelling | · | · | ✓ |
| SRO | No reaction on previous exposure to drug | · | · | ✓ |
| SRO | Pyrexia | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release